$NOC

Guggenheim raises Northrop Grumman stock price target on growth outlook

Guggenheim raised its price target on Northrop Grumman (NOC) to $640 from $612, maintaining a Buy rating. The stock surged 7.7% over the past week. NOC provided 2027 guidance with 5% to 7% revenue growth and margin expansion. Q3 earnings beat estimates at $7.89 per share, and full-year guidance was raised. Baird upgraded NOC to Outperform with a $675 price target.

Original reporting
Published Oct 21, 2026, 11:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NOC
Bullish
high confidence
Mentioned
$NOC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NOCBullishMed
01

Why it matters

The upgrade and higher target could trigger buying pressure, especially in the pre‑market session.

02

Market read

The fresh earnings beat and guidance lift are material for traders targeting defense stocks.

03

What to watch

Potential reliance on supplemental DoD funding could introduce downside risk.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Guggenheim analysts updated their valuation model after Northrop Grumman's Q3 earnings beat and stronger 2027 guidance.

Company-level read

Ticker impact

$NOCBullishHigh confidence
Context

Guggenheim raised its price target on Northrop Grumman to $640 and highlighted stronger 2027 guidance and Q3 earnings beat.

Expected impact

likely upward pressure as investors price in stronger earnings and guidance

Evidence & confidence

The new price target and earnings beat are fresh disclosures that can drive buying interest today.

Market effects

Defense sector may see broader rally on improved budget outlook.

U.S. defense stocks could benefit from the guidance lift.

Limited to investors focused on U.S. defense and aerospace equities.

Counterpoint

If the budget outlook stalls, the price target may be overly optimistic.

Key entities

  • Northrop Grumman

    U.S. defense contractor (ticker NOC).

  • Guggenheim

    Equity research firm that raised the price target.

Related articles

$RTXHighAI 8/10

Defense Earnings Week Opens With Three Raised Forecasts and Two Record Backlogs

RTX, Northrop Grumman, and GE Aerospace reported Q3 earnings, raising full-year guidance. RTX reported $25B sales, $2.26 adjusted EPS, and a $340B backlog. Northrop Grumman reported $11.1B sales, $7.89 EPS, and a $109.6B backlog. GE Aerospace reported $19B orders, $13.3B revenue, and $2.25 EPS. Lockheed Martin and L3Harris are set to report soon. NATO and U.S. defense spending commitments support sector growth.

$NOCMed

Plans firm up for local solid rocket motor production

Australia plans to locally produce solid rocket motors (SRMs) with Northrop Grumman, backed by $126.9 million in initial funding. The SRMs will be used in Lockheed Martin's Guided Multiple Launch Rocket System (GMLRS). Northrop Grumman aims to begin industry engagements for local suppliers, with a 2030 deadline for production. A test flight of an Australian-made SRM was successful in August, developed with Thales.

$NOCHighAI 8/10

Key facts: Northrop Grumman (NOC) Q3; B-21 rates up, $2.5B; 50 sats/6mo

Northrop Grumman (NOC) reported Q3 revenue of $11.12B (+7% YoY), net income of $1.124B, and EPS of $7.89. Bookings were $16.4B with a backlog of ~$110B and a book-to-bill ratio of 1.5. The company raised its 2026 adjusted EPS outlook, completed the IMS divestiture, and plans to increase B-21 production rates with a $2.5B investment. It also aims to deploy 50 of 150 Space Systems satellites within six months.